GlassScriptPhysician profile
Philip John Benyo
NPI 1184622391
$10,289.91
in general payments reported to CMS, 2019-2025
49 companies · $61.44 in 2025
The $61.44 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,494 · 2020: $1,396 · 2021: $2,420 · 2022: $2,361 · 2023: $2,558 · 2025: $61.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,532.54 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,445.76 | 2019-2023 | Otezla, Repatha, Evenity |
| Pfizer INC. | $955.30 | 2019-2023 | |
| Lilly USA, LLC | $715.57 | 2019-2023 | Mounjaro, Jardiance, Trulicity |
| Abbvie INC. | $609.45 | 2019-2023 | Ubrelvy, Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $521.12 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $419.72 | 2019-2023 | Arexvy, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $314.53 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $298.73 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.93 | 2020-2023 | Stiolto Respimat, Jardiance, Tradjenta |
| Mylan Specialty L.P. | $276.88 | 2019-2023 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $225.37 | 2019-2023 | Austedo Xr, Austedo |
| Bayer Healthcare Pharmaceuticals INC. | $207.55 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $204.11 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $192.96 | 2019-2023 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Benyo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.